An idiotypic network dysregulation could be related to the pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT) following vaccination with vaccines expressing Spike protein of SARS CoV2.
作者信息
Cañas Carlos A, Posso-Osorio Iván, Bedoya-Joaqui Vanessa, López Hugo E, Tobón Gabriel J
机构信息
Universidad Icesi, CIRAT: Grupo de Investigación en Reumatología, Autoinmunidad y Medicina Traslacional, Fundación Valle Del Lili and Universidad Icesi, Cali, Colombia.
Rheumatology Unit, Fundación Valle del Lili, Cra.98 No.18-49, 760032, Cali, Colombia.
出版信息
Intern Emerg Med. 2022 Jun;17(4):1249-1250. doi: 10.1007/s11739-022-02956-4. Epub 2022 Mar 6.
Abstract
摘要
相似文献
1
An idiotypic network dysregulation could be related to the pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT) following vaccination with vaccines expressing Spike protein of SARS CoV2.独特型网络失调可能与接种表达 SARS-CoV-2 刺突蛋白的疫苗后发生的疫苗诱导的免疫性血栓性血小板减少症（VITT）的发病机制有关。
Intern Emerg Med. 2022 Jun;17(4):1249-1250. doi: 10.1007/s11739-022-02956-4. Epub 2022 Mar 6.
2
Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.疑似 COVID-19 疫苗诱导（免疫性）血栓性血小板减少症的实验室检测。
Int J Lab Hematol. 2021 Aug;43(4):559-570. doi: 10.1111/ijlh.13629. Epub 2021 Jun 17.
3
Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination.疑似接种 ChAdOx1 nCoV-19 后出现 VITT 患者的临床评估路径。
Blood Adv. 2022 Jun 14;6(11):3315-3320. doi: 10.1182/bloodadvances.2021006862.
4
Transjugular intrahepatic portosystemic shunt, local thrombaspiration, and lysis for management of fulminant portomesenteric thrombosis and atraumatic splenic rupture due to vector-vaccine-induced thrombotic thrombocytopenia: a case report.经颈静脉肝内门体分流术、局部血栓抽吸和溶栓治疗疫苗诱导的血栓性血小板减少性紫癜所致暴发性门体系统血栓形成和非创伤性脾破裂：病例报告。
J Med Case Rep. 2022 Jul 11;16(1):271. doi: 10.1186/s13256-022-03464-x.
5
VITT with inactivated SARS-CoV-2 vaccine - index case.接种过灭活 SARS-CoV-2 疫苗的 VITT - 首例病例。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2036556. doi: 10.1080/21645515.2022.2036556. Epub 2022 Mar 7.
6
Eltrombopag for refractory vaccine-induced immune thrombotic thrombocytopenia.艾曲泊帕用于难治性疫苗诱导的免疫性血栓性血小板减少症。
J Thromb Thrombolysis. 2022 May;53(4):954-958. doi: 10.1007/s11239-021-02604-2. Epub 2021 Nov 19.
7
The psychiatric and psychological sequelae of vaccine-induced immune thrombotic thrombocytopenia (VITT).疫苗诱导的免疫性血栓性血小板减少症（VITT）的精神和心理后遗症。
Semin Hematol. 2022 Apr;59(2):115-119. doi: 10.1053/j.seminhematol.2022.02.003. Epub 2022 Feb 18.
8
Successful Treatment of Immune Thrombocytopenic Purpura with Intracranial Hemorrhaging and Duodenal Bleeding Following SARS-CoV-2 Vaccination.接种 SARS-CoV-2 疫苗后出现颅内出血和十二指肠出血的免疫性血小板减少性紫癜的成功治疗。
Intern Med. 2022 Jun 15;61(12):1891-1895. doi: 10.2169/internalmedicine.9199-21. Epub 2022 Apr 9.
9
Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT).社论：SARS-CoV-2 mRNA 疫苗与疫苗诱导的免疫性血栓性血小板减少症（VITT）的可能机制。
Med Sci Monit. 2021 Apr 26;27:e932899. doi: 10.12659/MSM.932899.
10
VITT and Second Doses of Covid-19 Vaccine.疫苗诱导的免疫性血小板减少症（VITT）与新冠病毒疾病-19疫苗第二剂
N Engl J Med. 2022 Jan 6;386(1):95. doi: 10.1056/NEJMc2118507. Epub 2021 Dec 22.
引用本文的文献
1
Autoantibodies Targeting G-Protein-Coupled Receptors and RAS-Related Molecules in Post-Acute COVID Vaccination Syndrome: A Retrospective Case Series Study.急性 COVID 疫苗接种后综合征中靶向 G 蛋白偶联受体和 RAS 相关分子的自身抗体：一项回顾性病例系列研究。
Biomedicines. 2024 Dec 15;12(12):2852. doi: 10.3390/biomedicines12122852.
2
Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2 infection: a literature review.螺内酯与 DPP-4 抑制剂联合治疗 SARS-CoV-2 感染：文献综述。
Arch Virol. 2024 May 16;169(6):122. doi: 10.1007/s00705-024-06043-1.
3
Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)-Insights from Clinical Cases, In Vitro Studies and Murine Models.疫苗诱导的免疫性血小板减少症和血栓形成（VITT）——来自临床病例、体外研究和小鼠模型的见解
J Clin Med. 2023 Sep 22;12(19):6126. doi: 10.3390/jcm12196126.
本文引用的文献
1
A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.抗独特型抗体在SARS-CoV-2感染和疫苗接种中的潜在作用。
N Engl J Med. 2022 Jan 27;386(4):394-396. doi: 10.1056/NEJMcibr2113694. Epub 2021 Nov 24.
2
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review.比较 COVID-19 疫苗在针对 SARS-CoV-2 及其关注变异株的特性、疗效和有效性方面的差异：一项叙述性综述。
Clin Microbiol Infect. 2022 Feb;28(2):202-221. doi: 10.1016/j.cmi.2021.10.005. Epub 2021 Oct 27.
3
Vaccine-induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources.疫苗诱导的免疫性血栓性血小板减少症（VITT）：考虑不同资源的诊断和管理更新。
J Thromb Haemost. 2022 Jan;20(1):149-156. doi: 10.1111/jth.15572. Epub 2021 Nov 10.
Zotero 插件